|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RET Recombinant Monoclonal Antibody [8D12]
Antibodies
Search result relevance score: 100%
Ret Monoclonal Antibody
Antibodies
Search result relevance score: 99.1%
Calreticulin Monoclonal Antibody
Knockout Validated
Antibodies
Search result relevance score: 81.7%
Secretagogin (SCGN) Monoclonal Antibody
Antibodies
Search result relevance score: 81.3%
Calretinin Monoclonal Antibody
Antibodies
Search result relevance score: 80.8%
Calretinin Monoclonal Antibody
Antibodies
Search result relevance score: 80.8%
RPE65 Recombinant Monoclonal Antibody [7B10]
Antibodies
Search result relevance score: 61.8%
RBP4 Recombinant Monoclonal Antibody [9G7]
Antibodies
Search result relevance score: 61.6%
RARA Recombinant Monoclonal Antibody [4A10]
Antibodies
Search result relevance score: 61.1%
APP Recombinant Monoclonal Antibody [6F10]
Antibodies
Search result relevance score: 61.1%
ATP2A2 Recombinant Monoclonal Antibody [20D1]
Antibodies
Search result relevance score: 60.9%
RBP4 Monoclonal Antibody
Antibodies
Search result relevance score: 60.9%
ALDH1A2 Monoclonal Antibody
Antibodies
Search result relevance score: 60.9%
RPE65 Monoclonal Antibody
Antibodies
Search result relevance score: 60.9%
RXRa Monoclonal Antibody
Antibodies
Search result relevance score: 60.7%
Human IgA Monoclonal Antibody
Antibodies
Search result relevance score: 60.7%
CD133 Monoclonal Antibody
Antibodies
Search result relevance score: 60.7%
TTR Monoclonal Antibody
Antibodies
Search result relevance score: 60.7%
CYP26A1 Monoclonal Antibody
Antibodies
Search result relevance score: 60.7%
CRALBP Monoclonal Antibody
Antibodies
Search result relevance score: 60.7%
|
| Terms & Conditions | Privacy Policy | Site Map |
| Copyright © EpigenTek Group Inc. All rights reserved. |